Studies Point Way to Precision Therapies for Common Genetic Disorders

News   Feb 10, 2017 | Original story from Princeton University, Engineering School

 
Studies Point Way to Precision Therapies for Common Genetic Disorders

The researchers include: (from left) Trudi Schüpbach, the Henry Fairfield Osborn Professor of Biology; Rebecca Burdine, associate professor of molecular biology; Stanislav Shvartsman, Professor of Chemical and Biological Engineering and the Lewis Sigler Institute for Integrative Genomics; and Yogesh Goyal and Granton Jindal, graduate students in chemical and biological engineering.

 
 
 
 

RELATED ARTICLES

Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?

News

A team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.

READ MORE

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

News

TheFDA has changed its accelerated approval of blinatumomab (Blincyto®) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.

READ MORE

GWAS Reveals Genes Associated with Lean Body Mass

News

Findings could lead to future therapies to preserve muscle mass as we age.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE